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INTRODUCTION
Diabetic nephropathy and chronic glomerulonephritis
represent common causes of end-stage renal disease
in Japan and the United States. The characteristic
glomerular findings with respect to these lesions are
both mesangial cell proliferation and the expansion
of the extracellular matrix (ECM) in the mesangial
area. Several mechanisms are thought to be involved
in the progression of renal injury (1). An epidemiological
investigation has shown that only 30-40% of patients
with diabetes mellitus progressed to diabetic nephropathy.
Recent findings, based on an experimental model and
human nephropathy, indicated that a predisposition
or resistance to the development of glomerulosclerosis
was a genetically determined trait. Hyperfiltration,
immune disorders, and metabolic disorders including
hyperglycemia may play an important role in the
development of glomerulosclerosis (1) (Figure 1).
A comparatively large number of progressive
glomerular diseases are characterized by initial
mesangial cell proliferation, which is followed by
glomerulosclerosis, and finally develops into end
stage kidney disease (2). Examples of this process
are membranoproliferative glomerulonephritis, diabetic
nephropathy and IgA nephropathy. Non-aniticoagulant
heparin, a potent inhibitior ofmesangial cell proliferation
in vitro, inhibits the development of glomerulosclerosis
in the renal ablation model. Treatment of anti-PDGF
also blocks mesangial proliferation in vivo, in the
model of anti-thy 1 glomerulonephritis (3). These
findings suggest that mesangial proliferation may
play an important role in the development of glomerular
lesions. The search for agents which are capable
of favorably regulating mesangial cell proliferation
are, therefore, of considerable clinical importance in
the area of progressive glomerular change. In the
present study, we discuss the pathological role of
mesangial proliferation in the progression of glomerular
injury.
Potent Mediator of Glomerular Cell Prolif-
eration
Currently available evidence suggests that a number
of growth peptides are involved in the regulation of
cell turnover via surface receptors and its intracellular
effect (4). Examples of these include insulin-like
growth factor I (IGF-I), platelet derived growth factor
(PDGF), epidermal growth factor (EGF) and trans-
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forming growth factor-β (TGF-β) (Table 1). Although
the turnover of glomerular cells in normal subjects
is tightly regulated, glomerular cell turnover is
markedly increased in the currently used models of
glomerulosclerosis, even when the glomerular cell
number is slightly increased only in advanced scle-
rotic lesions (5).
While viewed as leading to glomerular scarring,
glomerular cell numbers are regulated by a multi-
plicity of events, including survival, mitosis, differ-
entiation and cell death. In anti-thy1 glomerulonephritis,
apoptotic and mitotic cells are detected in the same
glomerulus, indicating that both processes can occur
simultaneously. A number of defining factors have
been proposed, which might trigger apoptosis in
glomerular cells (6) (Table 2). Evidence has accu-
mulated to suggest that direct responsibilities for
the rate of progression of glomerular disease is di-
rectly controlled by specific positive and negative cell
cycle regulators. However, the precise mechanisms
which are involved in controlling the glomerular cell
number in healthy and diseased conditions are not
completely understood.
Growth Arrest Gene 6 (Gas 6)
Gas 6 was cloned from mouse fibroblasts, which
had been grown under serum-starved conditions, and
represents growth arrest-specific gene 6. Gas 6 is a
homologue of protein S, which contains the epider-
mal growth factor-like domain and the sex hormone
binding domain. Gas 6 also contains 11 to 12 glutamic
acids residues, which are post-translationally modi-
fied by γ-carboxylase in the presence of vitamin K
(7) (Figure 2). This modification is selectively inhibited
by warfarin. Gas 6 specifically binds to tyrosine-kinase
receptors (Axl, Rse and Mer), of which the affinity
for Axl is remarkably high compared with that for
other receptors (8). It was recently reported that the
Table 1. Modulators for Mesangial Cell Proliferation
Sources of Factors
Endothelial Cell products
Blood-Borne Cells (Macrophages, T Cells, Platelets)
Plasma Hormones
Autocrine or Paracrine Products
Metabolic Products
Growth Promoters
IGF-1
PDGF
IL-1
IL-6
EGF
Basic FGF
TNFα
Growth Inhibitors
ANF
Heparin
TGF-β
INF-γ
Vitamin D Analog
Table 2. Stimulators for Mesangial Cell Apoptosis
Non-specific Factors
Serum Starvation
Detachment
Shear Stress
DNA damage
Reactive Oxygen Species
Radiation
Cytotoxic Drugs
Specific Promoters
IL-1
TNF-α
Gas 6
C1q
LDL
Lovastatin
NO
Superoxide
Cyclic AMP
Fig.1. Pathogenesis of Glomerular Injury
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γ-carboxylation of Gas 6 is essential for its receptor-binding
and growth-promoting activities in vascular smooth
muscle cells.
Gas 6 and its receptor, Axl, were expressed in
mesangial cells. The addition of exogenous Gas 6
led to phosphorylation of Axl, activated extracellular
signal-regulated kinase (Erk), and [3H]-thymidine
incorporation in mesangial cells. Conditioned me-
dium from mesangial cells was able to stimulate total
DNA synthesis and the phosphorylation of Erk, where-
as the addition of the extracellular domain of Axl
inhibited the mitogenic activity of the conditioned
medium from mesangial cells. Warfarin inhibited
mesangial cell proliferation, which was blocked by
the presence of vitamin K. This demonstrates that
Gas 6 is a new autocrine growth factor for mesangial
cells, and that warfarin inhibits mesangial cell pro-
liferation by inhibiting the γ-carboxylation of Gas 6
(9).
We examined the role of Gas 6/Axl in vivo in an
experimental glomerulonephritis model, which was
induced by anti-Thy1.1 antibody (Anti-thy1 GN) (10).
The expression of Gas 6 and Axl was markedly in-
creased in glomeruli in the glomerulonephritis. The
administration of Axl-Fc in the model inhibited
mesangial proliferation and abolished the induction
of PDGF-B. The administration of low doses of warfarin
also significantly inhibited mesangial proliferation.
These findings indicate that the Gas 6/Axl-pathway
played a critical role in glomerulonephritis.
Vitamin D Analog
1,25-dihydroxyvitamin D3 (1,25(OH)2D3) was origi-
nally identified as a nutritional factor and a fat-soluble
vitamin. Its physiological role is to regulate calcium
metabolism. It is generally accepted that the role of
1,25(OH)2D3 is to regulate the proliferation and dif-
ferentiation of a variety of cells (11). However, ef-
fective doses of 1,25(OH)2D3 causes severe side ef-
fects including hypercalcemia. To prevent these side
effects, a number of analogs of 1,25(OH)2D3 have
been examined. One of these, 22-oxa1,25(OH)2D3(OCT),
has a more potent differentiation effect than 1,25(OH)2D3,
but does not induce hypercalcemia (12) (Figure 3).
Mesangial cell proliferation is significantly inhibited
by OCT rather than 1,25(OH)2D3 in a dose-dependent
manner. The addition of neutralizing antibody to OCT
treated mesangial cells blocked the inhibitory effect
of cell proliferation, but OCT does not induce the se-
cretion of active TGF-β. OCT treatment significant-
ly increased the expression of the TGF-β type II
receptor. These findings suggest that the vitamin D
analog OCT is a new potent modulator for mesangial
cell proliferation and that this phenomenon was me-
diated via the induction of the type II receptor of
TGF-β (13).
The effect of OCT on anti-thy 1 glomerulonephritis
was examined (14). Both OCT and 1,25(OH)2D3 sig-
nificantly inhibited mesangial cell proliferation, the
degree of glomerulosclerosis, as well as albuminuria.
The OCT treated group showed normal calcium levels
but the 1,25(OH)2D3 treated group showed even higher
levels. These findings demonstrate that OCT inhibits
mesangial cell proliferation and extracellular matrix
expansion with a low calcemic activity. The suppres-
sive effect of OCT may be mediated by inhibition
of TGF-β1. In the present study, we found the different
mechanism of TGF-β between the disease state and
that in the in vitro cell study. The upregulation of TGF-β
may play a key role for developing glomerulosclerosis
in vivo, which is ameliorated by vitamin D analog.
Fig.2. Gas 6 (product of growth arrest gene 6)
1. Cloned from seum-starved fibroblast
2. It contained 11-12 Gla residues, 4 EGF-like domains and SHBG.
3. Structure similarity to Protein S.
4. Ligands for receptor tyrosine kinases.
Axl, Res, and Mer (Affinity : Axl > Res > Mer)
Gla : γ-carboxyglutamate
SHBG : sex hormone binding globulin
EGF : epidermal growth factor
Fig.3. Structure of Vitamin D Analogs
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The overall effect is also regulated by the actions of
TGF-β, its receptor and the different Smad family. In
conclusion, the present findings suggest that OCT
has potential for use in therapeutic strategies for the
treatment of glomerulonephritis without inducing
hypercalcemia.
CONCLUSION
Accumulating evidence suggests that glomerular
cell proliferation plays a key role in the progres-
sion of glomerular injury. The present findings sug-
gest that the regulation of proliferation is important
in the treatment of glomerulonephritis as shown in
figure 1.
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